Although accumulated evidence suggests the existence of a molecular link between VD3 and Bcl-2 in multiple tumor types, proapoptotic effects of VD3 remain to be elucidated at the cell biological level and in animal studies for each tumor type, including prostate cancer. Here, BCL2 is linked to prostate carcinoma.